Noci Darlene sold $2.5M of NUVL
Noci Darlene (Chief Development Officer) sold 20,000 shares of Nuvalent, Inc. (NUVL) at $122.81 ($2.46M total) on 2026-06-09 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the insider’s post-sale ownership and confirms the transaction was executed under a pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.
Market read
A scheduled insider sale updates ownership records; it is unlikely to be a standalone fundamental catalyst.
What to watch
Traders may over-weight insider sales; the key incremental data is the execution price and remaining holdings, not a change in company outlook.
Background
This is an SEC Form 4 insider transaction disclosure for Nuvalent, Inc.
Ticker impact
Nuvalent insider sale: CDO Noci Darlene sold 20,000 shares on 2026-06-09 at $122.81/share under a pre-arranged 10b5-1 plan.
Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.
The filing is a primary-source Form 4, but it is explicitly under a pre-arranged 10b5-1 plan and provides no new operating or regulatory catalyst.
Market effects
No direct sector read-through; this is company-specific insider transaction data.
None indicated.
None indicated.
Counterpoint
Because the sale is on a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish fundamentals.
Key entities
- issuerNuvalent, Inc.
Company whose insider transaction was disclosed on SEC Form 4.
- insiderNoci Darlene
Chief Development Officer who sold 20,000 shares.
- trading_mechanism10b5-1 plan
Pre-arranged plan that typically limits signaling value of insider sales.
